Closed vs. Open Abdomen Management for Sepsis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two methods of managing the abdomen after surgery for severe abdominal infections. One method involves immediate closure of the abdomen (CLOSED, or Closed Abdomen Management), while the other keeps it open temporarily with a special dressing and vacuum drain (OPEN, or Open Abdomen Management with ANPPT dressing). The study aims to determine which approach is more effective for treating this serious condition. Individuals who have experienced a major abdominal infection with leakage into the abdomen during surgery and are in septic shock may be suitable candidates for this trial. As an unphased trial, it offers patients the chance to contribute to important research that could enhance treatment options for severe abdominal infections.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these management techniques are safe for sepsis treatment?
Research shows that using an open abdomen management approach with a temporary abdominal closure (TAC) and negative pressure wound therapy (ANPPT) is generally safe, though risks exist. One study found that about 76.6% of patients successfully had their abdomen closed using this method. However, complications included a 7.2% chance of developing a fistula, an abnormal connection between organs, and 29.7% of patients experienced infection-related issues.
Other studies have shown that a vacuum-assisted closure system can achieve a high rate of successful abdominal closure, around 90%. However, patients with severe abdominal infections (abdominal sepsis) may face worse outcomes than those treated for injuries, with a higher chance of complications.
These findings suggest that while open abdomen management with ANPPT dressing is often effective, it carries some risk, especially in cases of severe infection.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it compares two different surgical techniques for managing sepsis, which is a life-threatening condition. The trial is evaluating whether keeping the abdomen closed with a drain or using an open abdomen approach with an ANPPT dressing is better. The open abdomen method uses a special dressing that applies negative pressure, which might help control infection and improve healing. This trial could provide valuable insights into which approach leads to better outcomes for patients with sepsis, potentially changing how this condition is managed in the future.
What evidence suggests that this trial's treatments could be effective for sepsis?
This trial will compare Closed Abdomen Management with Open Abdomen Management using an ANPPT dressing. Research has shown that a temporary abdominal closure (TAC) device, such as an ANPPT dressing, effectively treats severe abdominal infections. Studies have found that this method can increase the likelihood of successfully closing the abdominal wall later. It may also reduce death rates and shorten hospital stays for patients with severe abdominal infections. However, patients with abdominal infections might experience worse outcomes compared to those with injuries when using this method. Despite these challenges, incorporating negative pressure wound therapy (NPWT) into the TAC has effectively managed serious abdominal infections.14678
Who Is on the Research Team?
Andrew W Kirkpatrick, MD
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for adults with severe abdominal sepsis, indicated by specific scores like the World-Society-of-Emergency-Surgery-Sepsis-Severity Score >8. It's not for pregnant individuals, those with high intra-abdominal pressure (IAP>20 mmHg), patients without plans for continued care, cases of pancreatitis-induced peritonitis, or uncontrolled bleeding.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either closed or open abdomen management with ANPPT dressing after laparotomy for severe intra-abdominal infection
Follow-up
Participants are monitored for survival, blood IL-6 levels, and ICU stay duration
Post-operative Care
Formal abdominal closure or dressing change at 24-72 hours from placement
What Are the Treatments Tested in This Trial?
Interventions
- Closed Abdomen Management
- Open Abdomen Management with ANPPT dressing
Closed Abdomen Management is already approved in European Union, United States for the following indications:
- Abdominal sepsis
- Intra-abdominal infection
- Abdominal sepsis
- Intra-abdominal infection
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Alberta Health services
Collaborator